Lifecore Biomedical Signs 10-Year Manufacturing, Supply Deal With Ophthalmic Therapy Customer

Market Closed – Nasdaq			5-day change	1st Jan Change
6.670 ^USD	-0.89%		-2.63%	-10.23%

Published on 06/17/2025 at 08:27

This article is reserved for members

Unlock the article: REGISTER NOW!

Lifecore Biomedical Receives Remaining $10 Million for Sale of Isolator Filler Ahead of Schedule	Jun. 12	MT
Lifecore Biomedical Names Mark Dafonseca Chief Commercial Officer	May. 27	RE
Lifecore Biomedical, Inc. Appoints Mark DaFonseca as Chief Commercial Officer	May. 27	CI
William Blair Initiates Coverage on Lifecore Biomedical With Outperform Rating	May. 21	MT
Lifecore Biomedical, Inc. Appoints Thomas D. Salus as Chief Legal and Administration Officer	Apr. 14	CI
Sector Update: Health Care Stocks Fall Late Afternoon	Apr. 04	MT
Top Midday Decliners	Apr. 04	MT
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results	Apr. 03	RE
Lifecore Biomedical Q3 Swings to Loss, Revenue Lower	Apr. 03	MT
Lifecore Biomedical, Inc., Q3 2025 Earnings Call, Apr 03, 2025	Apr. 03
Lifecore Biomedical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 23, 2025	Apr. 03	CI
Lifecore Biomedical, Inc. Reiterates Financial Guidance for the Full Fiscal Year 2025	Apr. 03	CI
Humanetics Selects Lifecore Biomedical To Deliver CDMO Services Supporting Development Of BIO 300 For The Prevention Of Acute Radiation Syndrome	Mar. 17	RE
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome	Mar. 17	CI
Lifecore Biomedical, Inc. Enters into a Sales Agreement	Jan. 07	CI
Sector Update: Health Care Stocks Lean Higher Pre-Bell Friday	Jan. 03	MT
Sector Update: Health Care	Jan. 03	MT
Tranche Update on Lifecore Biomedical, Inc.’s Equity Buyback Plan announced on July 14, 2010.	Jan. 02	CI
Lifecore Biomedical, Inc., Q2 2025 Earnings Call, Jan 02, 2025	Jan. 02
Lifecore Biomedical Swings to Fiscal Q2 Loss, Higher Revenue	Jan. 02	MT
Lifecore Biomedical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 24, 2024	Jan. 02	CI
Nirsum Labs, Inc. Selects Lifecore Biomedical, Inc. to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment	Dec. 19	CI
Lifecore Biomedical Amends, Extends Credit Facility	Nov. 26	MT
Lifecore Biomedical, Inc. Provides Earnings Guidance for the Year 2025	Nov. 21	CI
Lifecore Biomedical, Inc. – Analyst/Investor Day	Nov. 21

Duration

Period

LFCR: Dynamic Chart

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

More about the company

Sell

Buy

Average target price

10.00USD

Spread / Average Target

+49.93%

Consensus

Exclusive-US Health Secretary Kennedy to address Gavi vaccine event amid funding pullback

Tesla seeks to keep Texas robotaxi data under wraps, regulator says

Oil prices are now the stock market’s biggest driver

Tesla shares soar after first robotaxi rides hit the road in Austin, Texas

Fed’s Bowman open to cutting rates at July policy meeting

Fiserv shares rise on stablecoin launch plans

Top Premarket Decliners | MarketScreener

Commercial Metals misses Q3 revenue estimates

Amazon’s premium beauty push may be a buffer against Trump’s tariffs

Why Another 30% Crash To $1,800 Is Coming — TradingView News

Inspired by Trump, Texas first to fund state ‘strategic’ bitcoin reserve

Myriad Moves: Will Trump Drop Another F-Bomb? Plus Predictions on Ethereum and Wimbledon

Bitcoin Crash To $100K Likely Due To Tariffs, War And Weather

Ethereum Price Eyes $2,800 Breakout as Call Options Dominate June 27 Expiry

Bitcoin Headed for One of the Largest Options Expiries of the Year

Exclusive-US Health Secretary Kennedy to address Gavi vaccine event amid funding pullback

Tesla seeks to keep Texas robotaxi data under wraps, regulator says

Oil prices are now the stock market’s biggest driver

Tesla shares soar after first robotaxi rides hit the road in Austin, Texas

Fed’s Bowman open to cutting rates at July policy meeting

Fiserv shares rise on stablecoin launch plans

Top Premarket Decliners | MarketScreener

Commercial Metals misses Q3 revenue estimates

Amazon’s premium beauty push may be a buffer against Trump’s tariffs

Why Another 30% Crash To $1,800 Is Coming — TradingView News

Inspired by Trump, Texas first to fund state ‘strategic’ bitcoin reserve

Myriad Moves: Will Trump Drop Another F-Bomb? Plus Predictions on Ethereum and Wimbledon

Bitcoin Crash To $100K Likely Due To Tariffs, War And Weather

Ethereum Price Eyes $2,800 Breakout as Call Options Dominate June 27 Expiry

Bitcoin Headed for One of the Largest Options Expiries of the Year

Lifecore Biomedical Signs 10-Year Manufacturing, Supply Deal With Ophthalmic Therapy Customer

Related Posts

Why Another 30% Crash To $1,800 Is Coming — TradingView News

Inspired by Trump, Texas first to fund state ‘strategic’ bitcoin reserve

How New Retirees are Navigating Current Uncertainty

Bitcoin, Ethereum, XRP broadly stall as Middle East tensions keep markets on edge

DDC Enterprise announces up to $528 million raise to accelerate Bitcoin treasury strategy

Transcript : Sonova Holding AG, 2025 Earnings Call, May 09, 2025

Recent Posts

Navigate Site

Lifecore Biomedical Signs 10-Year Manufacturing, Supply Deal With Ophthalmic Therapy Customer

Related Posts

Recent Posts

Navigate Site

Follow Us